Protein misfolding, congophilia, oligomerization, and defective amyloid processing in Preeclampsia

Science Translational Medicine

Volumn 6, Issue 245, 2014, Pages

  Buhimschi, Irina A ^a,b   Nayeri, Unzila A ^b   Zhao, Guomao ^a   Shook, Lydia L ^b   Pensalfini, Anna ^c   Funai, Edmund F ^d   Bernstein, Ira M ^e   Glabe, Charles G ^f,g   Buhimschi, Catalin S ^b,d  

^a OHIO STATE UNIVERSITY   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NEW YORK UNIVERSITY   (United States)

^d THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF VERMONT   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ADAM10 ENDOPEPTIDASE; ALBUMIN; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE 1; BETA SECRETASE 2; CERULOPLASMIN; GAMMA SECRETASE; IMMUNOGLOBULIN LIGHT CHAIN; INTERFERON; INTERFERON INDUCIBLE PROTEIN [6-16]; PRESENILIN 1; SERINE PROTEINASE INHIBITOR; SERPIN A1; UNCLASSIFIED DRUG; CONGO RED; EPITOPE; MESSENGER RNA; PROTEIN AGGREGATE; SECRETASE;

ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; INTRAUTERINE GROWTH RETARDATION; MATERNAL MORBIDITY; MORTALITY; OLIGOMERIZATION; PATHOPHYSIOLOGY; PERINATAL MORBIDITY; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DEGRADATION; PROTEIN FOLDING; PROTEIN MISFOLDING; PROTEIN PROCESSING; UPREGULATION; ENZYMOLOGY; GENETICS; IMMUNOLOGY; MATERNAL HYPERTENSION; METABOLISM; PATHOLOGY; PLACENTA; PRE-ECLAMPSIA; PROGNOSIS; PROTEIN MULTIMERIZATION; PROTEOMICS; ULTRASTRUCTURE; URINE;

AMYLOID BETA-PEPTIDES; AMYLOID PRECURSOR PROTEIN SECRETASES; CONGO RED; EPITOPES; FEMALE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; PROGNOSIS; PROTEIN AGGREGATES; PROTEIN FOLDING; PROTEIN MULTIMERIZATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOMICS; RNA, MESSENGER;

EID: 84940293414     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3008808     Document Type: Article

References (70)

1. K. S. Khan, D. Wojdyla, L. Say, A. M. Gülmezoglu, P. F. Van Look, WHO analysis of causes of maternal death: A systematic review. Lancet 367, 1066-1074 (2006).
2. ACOG Practice Bulletin 33. Diagnosis and Management of Preeclampsia and Eclampsia (American College of Obstetricians and Gynecologists, Washington, DC, 2002).
3. B. M. Sibai, C. L. Stella, Diagnosis and management of atypical preeclampsia-eclampsia. Am. J. Obstet. Gynecol. 200, 481.e1-481.e7 (2009).
4. B. Sibai, G. Dekker, M. Kupferminc, Pre-eclampsia. Lancet 365, 785-799 (2005). (Pubitemid 40311367)
5. A. A. Shamshirsaz, M. Paidas, G. Krikun, Preeclampsia, hypoxia, thrombosis, and inflammation. J. Pregnancy 2012, 374047 (2012).
6. B. M. Sibai, Biomarker for hypertension-preeclampsia: Are we close yet? Am. J. Obstetrics Gynecol. 197, 1-2 (2007). (Pubitemid 47001867)
7. W. Ramma, I. A. Buhimschi, G. Zhao, A. T. Dulay, U. A. Nayeri, C. S. Buhimschi, A. Ahmed, The elevation in circulating anti-angiogenic factors is independent of markers of neutrophil activation in preeclampsia. Angiogenesis 15, 333-340 (2012).
8. R. Boij, J. Svensson, K. Nilsson-Ekdahl, K. Sandholm, T. L. Lindahl, E. Palonek, M. Garle, G. Berg, J. Ernerudh, M. Jenmalm, L. Matthiesen, Biomarkers of coagulation, inflammation, and angiogenesis are independently associated with preeclampsia. Am. J. Reprod. Immunol. 68, 258-270 (2012).
9. U. D. Anderson, M. G. Olsson, K. H. Kristensen, B. Åkerström, S. R. Hansson, Review: Biochemical markers to predict preeclampsia. Placenta 33(Suppl.), S42-S47 (2012).
10. I. A. Buhimschi, G. Zhao, E. F. Funai, N. Harris, I. E. Sasson, I. M. Bernstein, G. R. Saade, C. S. Buhimschi, Proteomic profiling of urine identifies specific fragments of SERPINA1 and albumin as biomarkers of preeclampsia. Am. J. Obstet. Gynecol. 199, 551.e1-551.e6 (2008).
11. J. A. Huntington, Serpin structure, function and dysfunction. J. Thromb. Haemost. 9(Suppl. 1), 26-34 (2011).
12. P. Frid, S. V. Anisimov, N. Popovic, Congo red and protein aggregation in neurodegenerative diseases. Brain Res. Rev. 53, 135-160 (2007). (Pubitemid 44854214)
13. R. Kayed, E. Head, J. L. Thompson, T. M. McIntire, S. C. Milton, C. W. Cotman, C. G. Glabe, Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300, 486-489 (2003). (Pubitemid 36444329)
14. R. Kayed, A. Pensalfini, L. Margol, Y. Sokolov, F. Sarsoza, E. Head, J. Hall, C. Glabe, Annular protofibrils are a structurally and functionally distinct type of amyloid oligomer. J. Biol. Chem. 284, 4230-4237 (2009).
15. R. Kayed, E. Head, F. Sarsoza, T. Saing, C. W. Cotman, M. Necula, L. Margol, J. Wu, L. Breydo, J. L. Thompson, S. Rasool, T. Gurlo, P. Butler, C. G. Glabe, Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers. Mol. Neurodegener. 2, 18 (2007).
16. M. A. Smith, P. L. Richey, R. N. Kalaria, G. Perry, Elastase is associated with the neurofibrillary pathology of Alzheimer disease: A putative link between proteolytic imbalance and oxidative stress. Restor. Neurol. Neurosci. 9, 213-217 (1996). (Pubitemid 26227969)
17. M. A. Salameh, J. L. Robinson, D. Navaneetham, D. Sinha, B. J. Madden, P. N. Walsh, E. S. Radisky, The amyloid precursor protein/protease nexin 2 Kunitz inhibitor domain is a highly specific substrate of mesotrypsin. J. Biol. Chem. 285, 1939-1949 (2010).
18. M. Halimi, Y. Dayan-Amouyal, Z. Kariv-Inbal, Y. Friedman-Levi, T. Mayer-Sonnenfeld, R. Gabizon, Prion urine comprises a glycosaminoglycan-light chain IgG complex that can be stained by Congo red. J. Virol. Methods 133, 205-210 (2006).
19. R. P. Linke, Highly sensitive diagnosis of amyloid and various amyloid syndromes using Congo red fluorescence. Virchows Arch. 436, 439-448 (2000). (Pubitemid 30312159)
20. W. E. Klunk, R. F. Jacob, R. P. Mason, Quantifying amyloid β-peptide (Aβ) aggregation using the Congo red-Aβ (CR-Aβ) spectrophotometric assay. Analyt. Biochem. 266, 66-76 (1999). (Pubitemid 29024609)
21. R. Guidotti, D. Jobson, Detecting Preeclampsia: A Practical Guide (World Health Organization, Geneva, 2005).
22. C. S. Buhimschi, E. R. Norwitz, E. Funai, S. Richman, S. Guller, C. J. Lockwood, I. A. Buhimschi, Urinary angiogenic factors cluster hypertensive disorders and identify women with severe preeclampsia. Am. J. Obstet. Gynecol. 192, 734-741 (2005). (Pubitemid 40311263)
23. Y. Yoshiike, R. Kayed, S. C. Milton, A. Takashima, C. G. Glabe, Pore-forming proteins share structural and functional homology with amyloid oligomers. Neuromol. Med. 9, 270-275 (2007). (Pubitemid 350129702)
24. Y. Yoshiike, R. Minai, Y. Matsuo, Y. R. Chen, T. Kimura, A. Takashima, Amyloid oligomer conformation in a group of natively folded proteins. PLOS One 3, e3235 (2008).
25. E. Cerf, R. Sarroukh, S. Tamamizu-Kato, L. Breydo, S. Derclaye, Y. F. Dufrêne, V. Narayanaswami, E. Goormaghtigh, J. M. Ruysschaert, V. Raussens, Antiparallel β-sheet: A signature structure of the oligomeric amyloid β-peptide. Biochem. J. 421, 415-423 (2009).
26. A. Laganowsky, C. Liu, M. R. Sawaya, J. P. Whitelegge, J. Park, M. Zhao, A. Pensalfini, A. B. Soriaga, M. Landau, P. K. Teng, D. Cascio, C. Glabe, D. Eisenberg, Atomic view of a toxic amyloid small oligomer. Science 335, 1228-1231 (2012).
27. T. Shirahama, A. S. Cohen, High-resolution electron microscopic analysis of the amyloid fibril. J. Cell Biol. 33, 679-708 (1967).
28. J. D. Sipe, A. S. Cohen, Review: History of the amyloid fibril. J. Struct. Biol. 130, 88-98 (2000).
29. H. Z. Malina, System in biology leading to cell pathology: Stable protein-protein interactions after covalent modifications by small molecules or in transgenic cells. J. Biomed. Sci. 18, 7 (2011).
30. N. E. Hellman, S. Kono, H. Miyajima, J. D. Gitlin, Biochemical analysis of a missense mutation in aceruloplasminemia. J. Biol. Chem. 277, 1375-1380 (2002). (Pubitemid 34968893)
31. P. G. Winyard, R. C. Hider, S. Brailsford, A. F. Drake, J. Lunec, D. R. Blake, Effects of oxidative stress on some physiochemical properties of caeruloplasmin. Biochem. J. 258, 435-445 (1989). (Pubitemid 19075516)
32. S. Kumar, A. Dispenzieri, J. A. Katzmann, D. R. Larson, C. L. Colby, M. Q. Lacy, S. R. Hayman, F. K. Buadi, N. Leung, S. R. Zeldenrust, M. Ramirez-Alvarado, R. J. Clark, R. A. Kyle, S. V. Rajkumar, M. A. Gertz, Serum immunoglobulin free light-chain measurement in primary amyloidosis: Prognostic value and correlations with clinical features. Blood 116, 5126-5129 (2010).
33. J. M. Kelly, A. C. Porter, Y. Chernajovsky, C. S. Gilbert, G. R. Stark, I. M. Kerr, Characterization of a human gene inducible by α- and β-interferons and its expression in mouse cells. EMBO J. 5, 1601-1606 (1986).
34. M. G. Turri, K. A. Cuin, A. C. Porter, Characterisation of a novel minisatellite that provides multiple splice donor sites in an interferon-induced transcript. Nucleic Acids Res. 23, 1854-1861 (1995).
35. F. Chiti, C. M. Dobson, Protein misfolding, functional amyloid, and human disease. Annu. Rev. Biochem. 75, 333-366 (2006). (Pubitemid 44118036)
36. O. Conchillo-Solé, N. S. de Groot, F. X. Avilés, J. Vendrell, X. Daura, S. Ventura, AGGRESCAN: A server for the prediction and evaluation of "hot spots" of aggregation in polypeptides. BMC Bioinformatics 8, 65 (2007).
37. M. F. Knauer, B. Soreghan, D. Burdick, J. Kosmoski, C. G. Glabe, Intracellular accumulation and resistance to degradation of the Alzheimer amyloid A4/β protein. Proc. Natl. Acad. Sci. U. S. A. 89, 7437-7441 (1992).
38. D. Goldgaber, M. I. Lerman, O. W. McBride, U. Saffiotti, D. C. Gajdusek, Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease. Science 235, 877-880 (1987). (Pubitemid 17019124)
39. J. Kang, B. Müller-Hill, Differential splicing of Alzheimer's disease amyloid A4 precursor RNA in rat tissues: PreA4695 mRNA is predominantly produced in rat and human brain. Biochem. Biophys. Res. Commun. 166, 1192-1200 (1990). (Pubitemid 20068966)
40. B. De Strooper, R. Vassar, T. Golde, The secretases: Enzymes with therapeutic potential in Alzheimer disease. Nat. Rev. Neurol. 6, 99-107 (2010).
41. A. Schmitz, R. Tikkanen, G. Kirfel, V. Herzog, The biological role of the Alzheimer amyloid precursor protein in epithelial cells. Histochem. Cell Biol. 117, 171-180 (2002). (Pubitemid 34185623)
42. C. Haass, D. J. Selkoe, Cellular processing of β-amyloid precursor protein and the genesis of amyloid β-peptide. Cell 75, 1039-1042 (1993).
43. H. J. Clarris, B. Key, K. Beyreuther, C. L. Masters, D. H. Small, Expression of the amyloid protein precursor of Alzheimer's disease in the developing rat olfactory system. Brain Res. Dev. Brain Res. 88, 87-95 (1995).
44. V. Muresan, N. H. Varvel, B. T. Lamb, Z. Muresan, The cleavage products of amyloid-β precursor protein are sorted to distinct carrier vesicles that are independently transported within neurites. J. Neurosci. 29, 3565-3578 (2009).
45. K. Bordji, J. Becerril-Ortega, O. Nicole, A. Buisson, Activation of extrasynaptic, but not synaptic, NMDA receptors modifies amyloid precursor protein expression pattern and increases amyloid-β production. J. Neurosci. 30, 15927-15942 (2010).
46. T. Oltersdorf, L. C. Fritz, D. B. Schenk, I. Lieberburg, K. L. Johnson-Wood, E. C. Beattie, P. J. Ward, R. W. Blacher, H. F. Dovey, S. Sinha, The secreted form of the Alzheimer's amyloid precursor protein with the Kunitz domain is protease nexin-II. Nature 341, 144-147 (1989). (Pubitemid 19222774)
47. L. Ho, K. Fukuchi, S. G. Younkin, The alternatively spliced Kunitz protease inhibitor domain alters amyloid β protein precursor processing and amyloid β protein production in cultured cells. J. Biol. Chem. 271, 30929-30934 (1996). (Pubitemid 26404119)
48. M. Barrachina, E. Dalfó, B. Puig, N. Vidal, M. Freixes, E. Castaño, I. Ferrer, Amyloid-β deposition in the cerebral cortex in dementia with Lewy bodies is accompanied by a relative increase in AβPP mRNA isoforms containing the Kunitz protease inhibitor. Neurochem. Int. 46, 253-260 (2005).
49. Rare Disease Act of 2002; http://www.gpo.gov/fdsys/pkg/PLAW-107publ280/ html/PLAW-107publ280.htm [accesed 10 January 2013].
50. E. F. Funai, Y. Friedlander, O. Paltiel, E. Tiram, X. Xue, L. Deutsch, S. Harlap, Long-term mortality after preeclampsia. Epidemiology 16, 206-215 (2005). (Pubitemid 40314413)
51. F. H. Harlow, M. A. Brown, The diversity of diagnoses of preeclampsia. Hyperten. Preg. 20, 57-67 (2001). (Pubitemid 32672928)
52. P. Zhang, M. Schmidt, L. Cook, Maternal vasculopathy and histologic diagnosis of preeclampsia: Poor correlation of histologic changes and clinical manifestation. Am. J. Obstet. Gynecol. 194, 1050-1056 (2006).
53. A. J. Howie, D. B. Brewer, Optical properties of amyloid stained by Congo red: History and mechanisms. Micron 40, 285-301 (2009).
54. C. Wu, Z. Wang, H. Lei, W. Zhang, Y. Duan, Dual binding modes of Congo red to amyloid protofibril surface observed in molecular dynamics simulations. J. Am. Chem. Soc. 129, 1225-1232 (2007). (Pubitemid 46208593)
55. UNICEF-WHO, Antenatal Care in Developing Countries: Promises, Achievements and Missed Opportunities (World Health Organization, Geneva, 2003).
56. N. Murray, C. S. Homer, G. K. Davis, J. Curtis, G. Mangos, M. A. Brown, The clinical utility of routine urinalysis in pregnancy: A prospective study. Med. J. Austr. 177, 477-480 (2002). (Pubitemid 35373434)
57. S. Thangaratinam, A. Coomarasamy, F. O'Mahony, S. Sharp, J. Zamora, K. S. Khan, K. M. Ismail, Estimation of proteinuria as a predictor of complications of pre-eclampsia: A systematic review. BMC Med. 7, 10 (2009).
58. V. Maisnar, M. Tichy, J. Stulik, J. Vavrova, B. Friedecky, V. Palicka, J. Spirkova, L. Zaloudkova, L. Hernychova, J. Spacilova, T. Buchler, R. Hajek, The problems of proteinuria measurement in urine with presence of Bence Jones protein. Clin. Biochem. 44, 403-405 (2011).
59. N. Parker, A. C. Porter, Identification of a novel gene family that includes the interferoninducible human genes 6-16 and ISG12. BMC Genomics 5, 8 (2004).
60. R. E. Tanzi, R. D. Moir, S. L. Wagner, Clearance of Alzheimer's Aβ peptide: The many roads to perdition. Neuron 43, 605-608 (2004). (Pubitemid 39179722)
61. R. W. Carrell, D. A. Lomas, Conformational disease. Lancet 350, 134-138 (1997). (Pubitemid 27313650)
62. M. R. Hayden, S. C. Tyagi, M. M. Kerklo, M. R. Nicolls, Type 2 diabetes mellitus as a conformational disease. JOP 6, 287-302 (2005). (Pubitemid 41581749)
63. S. L. Cole, R. Vassar, The Alzheimer's disease β-secretase enzyme, BACE1. Mol. Neurodegen. 2, 22 (2007).
64. T. Cornelis, A. Odutayo, J. Keunen, M. Hladunewich, The kidney in normal pregnancy and preeclampsia. Sem. Nephrol. 31, 4-14 (2011).
65. B. M. Sibai, Imitators of severe pre-eclampsia. Sem. Perinatol. 33, 196-205 (2009).
66. R. C. Pattinson, M. Hall, Near misses: A useful adjunct to maternal death enquiries. Br. Med. Bull. 67, 231-243 (2003). (Pubitemid 38112004)
67. Publications Committee, Society for Maternal-Fetal Medicine, B. M. Sibai, Evaluation and management of severe preeclampsia before 34 weeks' gestation. Am. J. Obstet. Gynecol. 205, 191-198 (2011).
68. M. D. Griffin, L. M. Wilson, Y. F. Mok, A. S. Januszewski, A. M. Wilson, C. S. Karschimkus, E. Romas, A. B. Lee, T. Godfrey, M. Wong, L. Clemens, A. J. Jenkins, G. J. Howlett, Thioflavin T fluorescence in human serum: Correlations with vascular health and cardiovascular risk factors. Clin. Biochem. 43, 278-286 (2010).
69. M. Sakono, T. Zako, Amyloid oligomers: Formation and toxicity of Aβ oligomers. FEBS J. 277, 1348-1358 (2010).
70. J. Rybarska, B. Piekarska, B. Stopa, G. Zemanek, L. Konieczny, M. Nowak, M. Król, I. Roterman, A. Szymczakiewicz-Multanowska, Evidence that supramolecular Congo red is the sole ligation form of this dye for L chain lambda derived amyloid proteins. Folia Histochem. Cytobiol. 39, 307-314 (2001). (Pubitemid 33026344)